Nexalin Technology (NXL) Profit After Tax (2021 - 2026)
Nexalin Technology's (NXL) quarterly Profit After Tax came in at -$2.1 million in Q1 2026, down 5.45% year-on-year from -$2.2 million in Q1 2025, and up 11.77% quarter-over-quarter from -$2.4 million in Q4 2025.
Nexalin Technology (NXL) Profit After Tax (2021 - 2026) Analysis & Trends
Nexalin Technology's Profit After Tax history runs 6 years deep, the most recent figure standing at -$2.1 million for Q1 2026.
- On a quarterly basis, Profit After Tax fell 5.45% year-over-year to -$2.1 million in Q1 2026; TTM through Mar 2026 was -$8.3 million, a 2.6% increase from a year earlier, with the FY2025 full-year figure at -$8.2 million, down 8.08% from the prior year.
- Profit After Tax rose to -$2.1 million in Q1 2026 per NXL's latest filing, from -$2.4 million in the prior quarter.
- Across five years, Profit After Tax topped out at -$135401.0 in Q3 2022 and bottomed at -$2.8 million in Q4 2024.
- The 5-year median for Profit After Tax is -$1.3 million (2024), against an average of -$1.4 million.
- Across the five-year window, Profit After Tax surged 92.48% in 2022 and sank 1620.43% in 2023, its largest moves.
- Year by year, Profit After Tax stood at -$693364.0 in 2022, then retreated by 12.77% to -$781874.0 in 2023, then tumbled by 262.38% to -$2.8 million in 2024, then rose by 16.13% to -$2.4 million in 2025, then increased by 11.77% to -$2.1 million in 2026.
- Per Business Quant, the three latest NXL Profit After Tax figures stand at -$2.1 million (Q1 2026), -$2.4 million (Q4 2025), and -$2.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.66 Bn | 175.36 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 128.55 Bn | 125.68 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 108.38 Bn | 99.16 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 68.11 Bn | 66.66 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 47.19 Bn | 43.52 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 28.54 Bn | 27.42 Bn | 750.30 Mn | 199.50 Mn |
| 7 | GE HealthCare Technologies | 28.37 Bn | 26.09 Bn | 1.98 Bn | 411.00 Mn |
| 8 | Smith & Nephew | 26.90 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 25.53 Bn | 22.40 Bn | 2.07 Bn | 170.93 Mn |
| 10 | Nexalin Technology | 9.58 Mn | 6.87 Mn | 13,133.00 | -2.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.10 Mn |
| Dec 31, 2025 | -2.38 Mn |
| Sep 30, 2025 | -2.28 Mn |
| Jun 30, 2025 | -1.58 Mn |
| Mar 31, 2025 | -1.99 Mn |
| Dec 31, 2024 | -2.83 Mn |
| Sep 30, 2024 | -2.45 Mn |
| Jun 30, 2024 | -1.28 Mn |
| Mar 31, 2024 | -1.04 Mn |
| Dec 31, 2023 | -781,874.00 |
| Sep 30, 2023 | -2.33 Mn |
| Jun 30, 2023 | -830,417.00 |
| Mar 31, 2023 | -707,345.00 |
| Dec 31, 2022 | -693,364.00 |
| Sep 30, 2022 | -135,401.00 |
| Jun 30, 2022 | -462,405.00 |
| Mar 31, 2022 | -393,249.00 |
| Dec 31, 2021 | -595,928.00 |
| Sep 30, 2021 | -1.80 Mn |